Atara Biotherapeutics, Inc

$4.84
+0.01 (+0.31%)

Volume:

21.963K ($106.30K)

Market Capitalization:

$39.58M

Atara Biotherapeutics, Price Chart

Atara Biotherapeutics, Price Chart6:57 AM8:17 AM9:37 AM10:57 AM12:17 PM1:37 PM2:57 PM4.894.864.834.804.784.754.72

Atara Biotherapeutics, Volume Chart

Atara Biotherapeutics, Volume Chart6:57 AM8:17 AM9:37 AM10:57 AM12:17 PM1:37 PM2:57 PM5.33K4.57K3.81K3.05K2.29K1.52K762

Atara Biotherapeutics, Market Segments

Regular Trading Hours

+0.06(+1.25%)
Open$4.78
Close$4.84
Low$4.71
Low Change-0.07 (-1.46%)
High$4.89
High Change+0.11 (+2.30%)
Range$0.18
Volume21.963K
Dollar Volume$106.30K

Premarket

*No Trades in Segment

After Hours Yesterday

*No Trades in Segment

Regular Trading Hours Yesterday

+0.08(+1.59%)
Open$4.75
Close$4.83
Low$4.75
Low Change0.00 (0.00%)
High$5.16
High Change+0.41 (+8.64%)
Range$0.41
Volume38.959K
Dollar Volume$187.98K

Premarket Yesterday

-0.24(-5.01%)
Open$4.79
Close$4.55
Low$4.54
Low Change-0.25 (-5.22%)
High$4.79
High Change+0.00 (+0.00%)
Range$0.25
Volume17.343K
Dollar Volume$78.91K

Atara Biotherapeutics, Moving Averages

5 Day Moving Average (SMA5)$4.83
10 Day Moving Average (SMA10)$4.98
20 Day Moving Average (SMA20)$4.97
50 Day Moving Average (SMA50)$5.09
100 Day Moving Average (SMA100)$7.86
200 Day Moving Average (SMA200)$10.34

Atara Biotherapeutics, Statistics

Average Volume (30 Days)77.19K
P/E Ratio (Current)1.23
EPS (Current)$3.84
Dividend Yield0.00%
Free Cash Flow
Cash Ratio0.57
Current Ratio0.82
Quick Ratio0.82
Debt to Equity0.00
Enterprise Value$31.78M
EV to EBITDA0.84
EV to Sales0.26
Price to Book-1.05
Price to Cash Flow
Price to Free Cash Flow
Price to Sales0.33
Return on Assets1.62%
Return on Equity-0.85%

Atara Biotherapeutics, Stock Splits

There has been 1 stock split for Atara Biotherapeutics, (ATRA). The reverse stock split occured on June 20, 2024 and reduced the outstanding shares at a ratio of 25:1.

DateTypeRatio
Jun 20, 2024Reverse25:1

Atara Biotherapeutics, Dividends

There have been no dividends for Atara Biotherapeutics, (ATRA).